Evidence map›Paper›PMID 42714451›Full record

ArticleAntimicrobial agents and chemotherapy2026

Rapid broad-spectrum activity of molecular iodine against multidrug-resistant bacterial and fungal pathogens without residual staining.

Nandhana Nair, Arushi Sangal, Samuel Kim, Ilker Bayer, Victor Nizet, Elisabet Bjånes

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nandhana Nair *School of Biological Sciences, University of California San Diego, La Jolla, California, USA.
Arushi Sangal *School of Biological Sciences, University of California San Diego, La Jolla, California, USA.
Samuel KimSchool of Biological Sciences, University of California San Diego, La Jolla, California, USA.
Ilker BayerI2Pure Corporation, Hudson, Massachusetts, USA.ORCID 0000-0002-7951-8851
Victor NizetDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0003-3847-0422
Elisabet BjånesDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-2747-7699

Funding

I2Pure NA
6 · The paper itself

Abstract

Povidone iodine (PVP-I) is a widely used topical antiseptic with broad antimicrobial activity, but its clinical utility can be limited by skin irritation, slow drying, and persistent staining of skin, textiles, and surfaces. Here, we evaluated reformulated molecular iodine (I

Indexed as

Anti-Bacterial AgentsAnti-Infective Agents, LocalFungiIodinePovidone-IodineAntifungal AgentsBacteriaCandida albicansDrug Resistance, Multiple, BacterialEnterococcus faecalisKlebsiella pneumoniaeMicrobial Sensitivity TestsPseudomonas aeruginosaStaining and LabelingStaphylococcus aureusAnti-Bacterial AgentsAntifungal AgentsAnti-Infective Agents, LocalIodinePovidone-Iodinealternatives to antibioticsdisinfectantenvironmental decontaminationmolecular iodinemultidrug-resistant pathogens

Identifiers

PMID42714451
PMCPMC13689429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.